SCHEMBL5899663

SCHEMBL5899663

CCC(CC)C1CC1(C#N)C(=O)OCc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSL P07711 5/20 0.41
CTSS P25774 5/20 0.41
CTSB P07858 4/20 0.41
ALDH1A1 P00352 4/20 0.40
CYP3A4 P08684 6/20 0.39
TSHR P16473 5/20 0.39
CYP2C9 P11712 4/20 0.39
CYP2C19 P33261 3/20 0.39
LMNA P02545 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
DDB1 Q16531 1/20 0.38
CRBN Q96SW2 1/20 0.38
CTSK P43235 3/20 0.38
CYP1A2 P05177 2/20 0.38
MAPK1 P28482 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HSD17B10 Q99714 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18819598 0.72 CTSL (0.44) CTSLCTSSCTSBALDH1A1CYP3A4
SCHEMBL19210117 0.71 ADAM17 (0.41) CTSLCTSSCTSBALDH1A1CYP3A4
SCHEMBL31268160 0.69 ALDH1A1 (0.50) ALDH1A1TSHRKMT2ADDB1CRBN
SCHEMBL21504115 0.69 ALDH1A1 (0.46) CTSLCTSSCTSBALDH1A1KMT2A
SCHEMBL32674103 0.68 ALDH1A1 (0.53) ALDH1A1TSHRCYP2C19KMT2ADDB1
SCHEMBL21504135 0.68 ALDH1A1 (0.45) CTSLCTSSCTSBALDH1A1LMNA
SCHEMBL25707989 0.68 ALDH1A1 (0.49) ALDH1A1TSHRKMT2ADDB1CRBN
SCHEMBL30968715 0.68 ALDH1A1 (0.52) ALDH1A1TSHRLMNAKMT2ADDB1
SCHEMBL30968716 0.68 ALDH1A1 (0.52) ALDH1A1TSHRLMNAKMT2ADDB1
SCHEMBL11209553 0.68 SMN1; SMN2 (0.50) ALDH1A1CYP3A4TSHRCYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7030267-B2 Cycloproply β-amino acid derivatives WARNER-LAMBERT COMPANY, LLC (US) 2006-04-18 US disclosed
EP-1592661-A2 CYCLOPROPYL BETA-AMINO ACID DERIVATIVES Warner-Lambert Company LLC (US) 2005-11-09 EP disclosed
WO-2004065361-A2 CYCLOPROPYL BETA-AMINO ACID DERIVATIVES WARNER-LAMBERT COMPANY LLC (US) 2004-08-05 WO disclosed
US-20040147608-A1 Cyclopropyl beta-amino acid derivatives SCHWARZ JACOB BRADLEY (US) 2004-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040147608-A1 Cyclopropyl beta-amino acid derivatives CACNA1S, CACNA1D, CACNA1B CTSL 2942/4885CTSS 2824/4885CTSB 3287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.